-
1
-
-
84892795827
-
Breast cancer statistics, 2013
-
DeSantis C, Ma J, Bryan L, et al. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64:52-62.
-
(2014)
CA Cancer J Clin.
, vol.64
, pp. 52-62
-
-
DeSantis, C.1
Ma, J.2
Bryan, L.3
-
2
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687-1717.
-
(2005)
Lancet
, vol.365
, pp. 1687-1717
-
-
-
3
-
-
33645834966
-
Metastatic patterns in adenocarcinoma
-
Hess KR, Varadhachary GR, Taylor SH, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106:1624-1633.
-
(2006)
Cancer
, vol.106
, pp. 1624-1633
-
-
Hess, K.R.1
Varadhachary, G.R.2
Taylor, S.H.3
-
4
-
-
0037301972
-
Survival of patients with metastatic breast carcinoma: Importance of prognostic markers of the primary tumor
-
Chang J, Clark GM, Allred DC, et al. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor. Cancer. 2003;97:545-553.
-
(2003)
Cancer
, vol.97
, pp. 545-553
-
-
Chang, J.1
Clark, G.M.2
Allred, D.C.3
-
5
-
-
57449098840
-
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers
-
Chia S, Norris B, Speers C, et al. Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers. J Clin Oncol. 2008;26:5697-5704.
-
(2008)
J Clin Oncol.
, vol.26
, pp. 5697-5704
-
-
Chia, S.1
Norris, B.2
Speers, C.3
-
6
-
-
0021925411
-
Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients
-
Alanko A, Heinonen E, Scheinin T, et al. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients. Cancer. 1985;56:1696-1700.
-
(1985)
Cancer
, vol.56
, pp. 1696-1700
-
-
Alanko, A.1
Heinonen, E.2
Scheinin, T.3
-
7
-
-
38649109161
-
An overview of prognostic factors for long-term survivors of breast cancer
-
Soerjomataram I, Louwman MW, Ribot JG, et al. An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat. 2008;107:309-330.
-
(2008)
Breast Cancer Res Treat.
, vol.107
, pp. 309-330
-
-
Soerjomataram, I.1
Louwman, M.W.2
Ribot, J.G.3
-
8
-
-
0024708518
-
The distribution of secondary growths in cancer of the breast. 1889
-
Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev. 1989;8:98-101.
-
(1989)
Cancer Metastasis Rev.
, vol.8
, pp. 98-101
-
-
Paget, S.1
-
9
-
-
0000629930
-
Selection of successive tumour lines for metastasis
-
Fidler IJ Selection of successive tumour lines for metastasis. Nat New Biol. 1973;242:148-149.
-
(1973)
Nat New Biol.
, vol.242
, pp. 148-149
-
-
Fidler, I.J.1
-
10
-
-
48149106931
-
Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients
-
Kriege M, Seynaeve C, Meijers-Heijboer H, et al. Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients. Breast Cancer Res Treat. 2008;111(2):303-311.
-
(2008)
Breast Cancer Res Treat.
, vol.111
, Issue.2
, pp. 303-311
-
-
Kriege, M.1
Seynaeve, C.2
Meijers-Heijboer, H.3
-
11
-
-
0025779949
-
Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group
-
Koenders PG, Beex LV, Langens R, et al. Steroid hormone receptor activity of primary human breast cancer and pattern of first metastasis. The Breast Cancer Study Group. Breast Cancer Res Treat. 1991;18:27-32.
-
(1991)
Breast Cancer Res Treat.
, vol.18
, pp. 27-32
-
-
Koenders, P.G.1
Beex, L.V.2
Langens, R.3
-
12
-
-
79952697149
-
Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs
-
Wei S, Li Y, Siegal GP, et al. Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs. Ann Diagn Pathol. 2011;15:79-83.
-
(2011)
Ann Diagn Pathol.
, vol.15
, pp. 79-83
-
-
Wei, S.1
Li, Y.2
Siegal, G.P.3
-
13
-
-
77953346211
-
Breast cancer brain metastases: Differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
-
Niwinska A, Murawska M, Pogoda K. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Ann Oncol. 2010;21:942-948.
-
(2010)
Ann Oncol.
, vol.21
, pp. 942-948
-
-
Niwinska, A.1
Murawska, M.2
Pogoda, K.3
-
14
-
-
77954740501
-
Metastatic behavior of breast cancer subtypes
-
Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28:3271-3277.
-
(2010)
J Clin Oncol.
, vol.28
, pp. 3271-3277
-
-
Kennecke, H.1
Yerushalmi, R.2
Woods, R.3
-
15
-
-
0034680102
-
Molecular portraits of human breast tumours
-
Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-752.
-
(2000)
Nature
, vol.406
, pp. 747-752
-
-
Perou, C.M.1
Sorlie, T.2
Eisen, M.B.3
-
16
-
-
33744960226
-
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
-
Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295:2492-2502.
-
(2006)
JAMA
, vol.295
, pp. 2492-2502
-
-
Carey, L.A.1
Perou, C.M.2
Livasy, C.A.3
-
17
-
-
44849114353
-
Subtypes of breast cancer show preferential site of relapse
-
Smid M, Wang YX, Zhang Y, et al. Subtypes of breast cancer show preferential site of relapse. Cancer Res. 2008;68:3108-3114.
-
(2008)
Cancer Res.
, vol.68
, pp. 3108-3114
-
-
Smid, M.1
Wang, Y.X.2
Zhang, Y.3
-
18
-
-
23144461051
-
Genes that mediate breast cancer metastasis to lung
-
Minn AJ, Gupta GP, Siegel PM, et al. Genes that mediate breast cancer metastasis to lung. Nature. 2005;436:518-524.
-
(2005)
Nature
, vol.436
, pp. 518-524
-
-
Minn, A.J.1
Gupta, G.P.2
Siegel, P.M.3
-
19
-
-
34147211281
-
Lung metastasis genes couple breast tumor size and metastatic spread
-
Minn AJ, Gupta GP, Padua D, et al. Lung metastasis genes couple breast tumor size and metastatic spread. Proc Natl Acad Sci U S A. 2007;104:6740-6745.
-
(2007)
Proc Natl Acad Sci U S A
, vol.104
, pp. 6740-6745
-
-
Minn, A.J.1
Gupta, G.P.2
Padua, D.3
-
20
-
-
67649300721
-
Genes that mediate breast cancer metastasis to the brain
-
Bos PD, Zhang XHF, Nadal C, et al. Genes that mediate breast cancer metastasis to the brain. Nature. 2009;459:1005-1009.
-
(2009)
Nature
, vol.459
, pp. 1005-1009
-
-
Bos, P.D.1
Zhang, X.H.F.2
Nadal, C.3
-
21
-
-
70349728696
-
Estrogen and progesterone receptor expression is not always specific for mammary and gynecologic carcinomas: A tissue microarray and pooled literature review study
-
Wei S, Said-Al-Naief N, Hameed O. Estrogen and progesterone receptor expression is not always specific for mammary and gynecologic carcinomas: a tissue microarray and pooled literature review study. Appl Immunohistochem Mol Morphol. 2009;17:393-402.
-
(2009)
Appl Immunohistochem Mol Morphol.
, vol.17
, pp. 393-402
-
-
Wei, S.1
Said-Al-Naief, N.2
Hameed, O.3
-
22
-
-
51349157679
-
Using a higher cutoff for the percentage of HER2+ cells decreases interobserver variability in the interpretation of HER2 immunohistochemical analysis
-
Hameed O, Adams AL, Baker AC, et al. Using a higher cutoff for the percentage of HER2+ cells decreases interobserver variability in the interpretation of HER2 immunohistochemical analysis. Am J Clin Pathol. 2008;130:425-427.
-
(2008)
Am J Clin Pathol.
, vol.130
, pp. 425-427
-
-
Hameed, O.1
Adams, A.L.2
Baker, A.C.3
-
23
-
-
79960980007
-
Strategies for subtypes - Dealing with the diversity of breast cancer: Highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
-
Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736-1747.
-
(2011)
Ann Oncol.
, vol.22
, pp. 1736-1747
-
-
Goldhirsch, A.1
Wood, W.C.2
Coates, A.S.3
-
24
-
-
84869811250
-
Molecular subclasses of breast cancer: How do we define them? The IMPAKT 2012 Working Group Statement
-
Guiu S, Michiels S, Andre F, et al. Molecular subclasses of breast cancer: how do we define them? the IMPAKT 2012 Working Group Statement. Ann Oncol. 2012;23:2997-3006.
-
(2012)
Ann Oncol.
, vol.23
, pp. 2997-3006
-
-
Guiu, S.1
Michiels, S.2
Andre, F.3
-
25
-
-
84906805668
-
Luminal B breast cancer: Molecular characterization, clinical management, and future perspectives
-
[published online July 21, 2014]
-
Ades F, Zardavas D, Bozovic-Spasojevic I, et al. Luminal B breast cancer: molecular characterization, clinical management, and future perspectives [published online July 21, 2014]. J Clin Oncol.
-
J Clin Oncol.
-
-
Ades, F.1
Zardavas, D.2
Bozovic-Spasojevic, I.3
-
26
-
-
84879901369
-
Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles
-
Gazinska P, Grigoriadis A, Brown JP, et al. Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles. Mod Pathol. 2013;26:955-966.
-
(2013)
Mod Pathol.
, vol.26
, pp. 955-966
-
-
Gazinska, P.1
Grigoriadis, A.2
Brown, J.P.3
-
27
-
-
34047217348
-
COX-2 involvement in breast cancer metastasis to bone
-
Singh B, Berry JA, Shoher A, et al. COX-2 involvement in breast cancer metastasis to bone. Oncogene. 2007;26:3789-3796.
-
(2007)
Oncogene
, vol.26
, pp. 3789-3796
-
-
Singh, B.1
Berry, J.A.2
Shoher, A.3
-
28
-
-
80052666221
-
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: A nationwide cohort study
-
Sihto H, Lundin J, Lundin M, et al. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res. 2011;13:R87.
-
(2011)
Breast Cancer Res.
, vol.13
, pp. R87
-
-
Sihto, H.1
Lundin, J.2
Lundin, M.3
-
29
-
-
7944223780
-
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
-
Li YM, Pan Y, Wei YK, et al. Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell. 2004;6:459-469.
-
(2004)
Cancer Cell
, vol.6
, pp. 459-469
-
-
Li, Y.M.1
Pan, Y.2
Wei, Y.K.3
-
31
-
-
33646869874
-
Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
-
Pestalozzi BC, Zahrieh D, Price KN, et al. Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann Oncol. 2006;17:935-944.
-
(2006)
Ann Oncol.
, vol.17
, pp. 935-944
-
-
Pestalozzi, B.C.1
Zahrieh, D.2
Price, K.N.3
-
32
-
-
33744813556
-
Genes associated with breast cancer metastatic to bone
-
Smid M, Wang Y, Klijn JG, et al. Genes associated with breast cancer metastatic to bone. J Clin Oncol. 2006;24:2261-2267.
-
(2006)
J Clin Oncol.
, vol.24
, pp. 2261-2267
-
-
Smid, M.1
Wang, Y.2
Klijn, J.G.3
-
33
-
-
33846459466
-
Sorting out breast-cancer gene signatures
-
Massague J. Sorting out breast-cancer gene signatures. N Engl J Med. 2007;356:294-297.
-
(2007)
N Engl J Med.
, vol.356
, pp. 294-297
-
-
Massague, J.1
-
34
-
-
84875732582
-
Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update
-
Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:961-965.
-
(2013)
J Clin Oncol.
, vol.31
, pp. 961-965
-
-
Khatcheressian, J.L.1
Hurley, P.2
Bantug, E.3
-
35
-
-
84863646635
-
Adjuvant therapy in stage I carcinoma of the breast: The influence of multigene analyses and molecular phenotyping
-
Schwartz GF, Bartelink H, Burstein HJ, et al. Adjuvant therapy in stage I carcinoma of the breast: the influence of multigene analyses and molecular phenotyping. Breast J. 2012;18:303-311.
-
(2012)
Breast J.
, vol.18
, pp. 303-311
-
-
Schwartz, G.F.1
Bartelink, H.2
Burstein, H.J.3
-
36
-
-
84884958436
-
Interobserver concordance in implementing the 2010 ASCO/CAP recommendations for reporting ER in breast carcinomas: A demonstration of the difficulties of consistently reporting low levels of ER expression by manual quantification
-
Reisenbichler ES, Lester SC, Richardson AL, et al. Interobserver concordance in implementing the 2010 ASCO/CAP recommendations for reporting ER in breast carcinomas: a demonstration of the difficulties of consistently reporting low levels of ER expression by manual quantification. Am J Clin Pathol. 2013;140:487-494.
-
(2013)
Am J Clin Pathol.
, vol.140
, pp. 487-494
-
-
Reisenbichler, E.S.1
Lester, S.C.2
Richardson, A.L.3
-
37
-
-
84890254448
-
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
-
Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31:3997-4013.
-
(2013)
J Clin Oncol.
, vol.31
, pp. 3997-4013
-
-
Wolff, A.C.1
Hammond, M.E.2
Hicks, D.G.3
-
38
-
-
84871762532
-
Effect of ASCO/CAP guidelines for determining ER status on molecular subtype
-
Deyarmin B, Kane JL, Valente AL, et al. Effect of ASCO/CAP guidelines for determining ER status on molecular subtype. Ann Surg Oncol. 2013;20:87-93.
-
(2013)
Ann Surg Oncol.
, vol.20
, pp. 87-93
-
-
Deyarmin, B.1
Kane, J.L.2
Valente, A.L.3
-
39
-
-
42249099793
-
Heterogeneity of breast cancer metastases: Comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases
-
Wu JM, Fackler MJ, Halushka MK, et al. Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res. 2008;14:1938-1946.
-
(2008)
Clin Cancer Res.
, vol.14
, pp. 1938-1946
-
-
Wu, J.M.1
Fackler, M.J.2
Halushka, M.K.3
-
40
-
-
77951952801
-
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases
-
Aitken SJ, Thomas JS, Langdon SP, et al. Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases. Ann Oncol. 2010;21:1254-1261.
-
(2010)
Ann Oncol.
, vol.21
, pp. 1254-1261
-
-
Aitken, S.J.1
Thomas, J.S.2
Langdon, S.P.3
-
41
-
-
69849090104
-
Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?
-
Simmons C, Miller N, Geddie W, et al. Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases? Ann Oncol. 2009;20:1499-1504.
-
(2009)
Ann Oncol.
, vol.20
, pp. 1499-1504
-
-
Simmons, C.1
Miller, N.2
Geddie, W.3
|